interferometric Nanoparticle Tracking Analysis

Determine particle size and concentration using an interferometric measurement principle called iNTA. It also provides label-free material information for each tracked particle , making it especially relevant for extracellular vesicles (e.g. exosomes), viral vectors, and lipid nanoparticles.

Label-Free        

Nanoparticle Tracking

iNTA: A direct path to bioparticle size, concentration, and composition

Interferometric Nanoparticle Tracking Analysis (iNTA) provides fast, label‑free nanoparticle characterization for teams working on gene and cell therapy vectors, extracellular vesicles, and next‑generation delivery systems, offering immediate insights into critical quality attributes (CQAs) across Exosomes, AdV, LNP, and more.

What is interferometric Nanoparticle Tracking?

In this video we explain how interferometric Nanoparticle Tracking works and why it performs much better than DLS or darkfield Nanoparticle Tracking.
"Interferometric Nanoparticle Tracking Analysis enables label-free discrimination of extracellular vesicles from large lipoproteins".

Comparison: NTA vs. iNTA

 NTA
(darkfield)
iNTA
(interferometry)
Size Resolutiongoodvery good
Concentrationsingle populationmulti population
Particle Propertiessizesize + refractive index
Plate Readernoyes
Well Plate Format-18-well plate
Sample Volume250–1,000 µL50–100 µL
Sample Conservationlowhigh

Meet iNTApharma: interferometric Nanoparticle Tracking Analyzer

iNTApharma is Bruker’s interferometric Nanoparticle Tracking Analysis system for biological nanoparticle characterization.

It provides the core information researchers expect from NTA: particle-by-particle size measurement and particle concentration. But iNTApharma goes further by adding interferometric optical contrast for each tracked particle, creating a richer 2D view of nanoparticle samples. Instead of reporting size and total concentration alone, iNTApharma helps users inspect particle populations by size and optical contrast.

Label-free, particle by particle, iNTApharma supports Nanoparticle Tracking Analysis for biological nanoparticles including extracellular vesicles, exosomes, lipid nanoparticles, and viral vectors. In addition to particle size and concentration, iNTA adds optical contrast information for each tracked particle, supporting label-free, particle-by-particle analysis of complex and polydisperse samples.

Exosome Analysis by iNTA

What Are Exosomes?

Exosomes are a subtype of extracellular vesicles (EVs), a heterogeneous class of membrane-bound particles released by cells into the extracellular environment. Typically ranging from 30–150 nm in diameter, exosomes originate from the endosomal pathway and are secreted through the fusion of multivesicular bodies with the plasma membrane. While EVs also include microvesicles and apoptotic bodies, exosomes have emerged as a major focus of research due to their role in cell-to-cell communication and their potential as disease biomarkers.

Why Analyze Exosomes with iNTA?

The isolation of exosomes often results in complex samples that may also contain lipoproteins, protein aggregates, and other nanoparticle populations overlapping in size. Conventional size-based characterization alone can therefore be insufficient to fully understand sample composition.

By combining particle tracking with interferometric optical contrast, iNTA adds an additional analytical dimension for exosome characterization:

  • Label-Free Population Analysis: Differentiate exosome-related particle populations from co-isolated nanoparticles using size and interferometric optical contrast.
  • Exceptional Resolution: .Resolve exosome size distributions with a level of detail comparable to electron microscopy, while maintaining the advantages of solution-based measurements.
  • Saves you time and sample: Perform repeated measurements using low sample volumes, automated plate-based handling, and an integrated 18-well workflow.
     
View each tracked particle by size and optical contrast, instead of relying only on one-dimensional size distributions.


Go Beyond Counting and Sizing

iNTApharma extends traditional exosome analysis beyond particle concentration and size determination. By visualizing individual particles according to both size and optical contrast, researchers can investigate sample heterogeneity and identify which particle populations contribute to the overall measurement.

Rather than relying solely on one-dimensional size distributions, iNTA provides multidimensional insight into complex exosome preparations.


Application Note: Label-Free Discrimination of Exosomes

This application note highlights how interferometric Nanoparticle Tracking Analysis (iNTA) achieves label-free discrimination of exosomes from co-isolates like lipoproteins in complex biological fluids. It is a vital read for researchers seeking to bypass the limitations of traditional size-based separation and fluorescence labeling.

Viral Vector Analysis by iNTA

What Are Viral Vectors?

Viral vectors are engineered viruses used to deliver genetic material into cells and are a foundational technology in gene therapy, cell therapy, and vaccine development. Common vector platforms include adenoviral vectors (AdV), adeno-associated viruses (AAV), and lentiviral vectors.

The successful development and manufacturing of viral vectors depend on accurate characterization of critical quality attributes (CQAs), including particle size, concentration, purity, and the presence of unwanted particle populations. Reliable analytical methods are therefore essential for ensuring product quality and process consistency.

Why Analyze Viral Vectors with iNTA

The isolation of exosomes often results in complex samples that may also contain lipoproteins, protein aggregates, and other nanoparticle populations overlapping in size. Conventional size-based characterization alone can therefore be insufficient to fully understand sample composition.

By combining particle tracking with interferometric optical contrast, iNTA adds an additional analytical dimension for exosome characterization:

  • Label-Free Population Analysis: Differentiate exosome-related particle populations from co-isolated nanoparticles using size and interferometric optical contrast.
  • Exceptional Resolution: .Resolve exosome size distributions with a level of detail comparable to electron microscopy, while maintaining the advantages of solution-based measurements.
  • Saves you time and sample: Perform repeated measurements using low sample volumes, automated plate-based handling, and an integrated 18-well workflow.
     
2D scattering plots of two adenoviral vectors (AdV) samples measured via interferometric nanoparticle tracking analysis (iNTA).


Go Beyond Size and Particle Counts

Traditional particle analysis methods often rely solely on size distributions, making it difficult to identify subpopulations with similar sizes but different physical characteristics.

iNTA visualizes every tracked particle according to both size and optical contrast, creating a multidimensional representation of the sample. This allows researchers to distinguish intact viral vectors from contaminants or other particle populations and evaluate sample purity on a particle-by-particle basis.

Rather than relying on one-dimensional size information alone, iNTA provides a more complete picture of viral vector quality and sample complexity.


Application Note: Quality Assessment of Adenoviral Vectors

This application note details how interferometric Nanoparticle Tracking Analysis (iNTA) provides high-resolution, label-free quality control for adenoviral vectors (AdV). It is essential for researchers needing to distinguish intact viruses from contaminants or empty capsids, a task challenging for conventional methods like DLS or NTA.

Recent Publications on iNTA

Employing high‑resolution interferometric Nanoparticle Tracking Analysis to investigate how freezing‑induced accelerated ageing enhances the homogeneity, stability, and reproducibility of red blood cell‑derived extracellular vesicles for biomaterial applications.

Learn more here:

Red blood cell‑derived extracellular vesicles as biomaterials: the opportunity of freezing‑induced accelerated aging

Paolini, L., Romano, M., Mangolini, V., Tassoni, S., Jiang, S., Mazzoldi, E. L., Musicò, A., Zendrini, A., Kashkanova, A., Sandoghdar, V., Berardi, A. C., Giliani, S. C., Bergese, P., Radeghieri, A.

Biomaterials Science, 14, 122–139, 2026

Employing interferometric Nanoparticle Tracking Analysis (iNTA) to enable quantitative, calibration‑free measurements of nanoparticle concentrations in complex and polydisperse liquid mixtures.

Learn more here:

Measuring Concentration of Nanoparticles in Polydisperse Mixtures Using iNTA

Kashkanova, A. D., Albrecht, D., Küppers, M., Blessing, M., Sandoghdar, V.

ACS Nano, published online July 9, 2024

Applying interferometric Nanoparticle Tracking Analysis for label‑free differentiation and accurate quantification of extracellular vesicles in complex biological samples containing large lipoproteins.

Learn more here:

Label‑free discrimination of extracellular vesicles from large lipoproteins

Kashkanova, A. D., Blessing, M., Reischke, M., Baur, J.-O., Baur, A. S., Sandoghdar, V., Van Deun, J.

Journal of Extracellular Vesicles, 12(8), 2023

Employing interferometric Nanoparticle Tracking Analysis (iNTA) to enable high‑precision, non‑invasive measurement of size and refractive index distributions in weakly scattering nanoparticles within complex and polydisperse liquid samples.

Learn more here:

Precision size and refractive index analysis of weakly scattering nanoparticles in polydispersions

Kashkanova, A. D., Blessing, M., Gemeinhardt, A., Soulat, D., Sandoghdar, V.

Nature Methods, 19(5), 586–593, 2022

Get in touch with our iNTA experts

Directly talk to our application experts and learn how iNTA can support your work.